Freitag, 22. Juni 2018


  • Pressemitteilung BoxID 302467

51% sales increase to EUR 9.8 million in the first quarter 2012

Berlin, (lifePR) - Preliminary figures indicate that aap Implantate AG (XETRA: AAQ.DE), a global medical device company focused on innovative trauma products and biomaterials for the orthopaedic market, achieved total sales in the first quarter of 2012 of EUR 9.8 million, a 51% increase on the previous year's figure of EUR 6.5 million. The sales growth was driven by an 18% increase in sales on product level to EUR 7.7 million (previous year: EUR 6.5 million) as well as from the sales of EUR 2.1 million from the exclusive license agreement with a world-leading medical technology company announced on March 23, 2012.

Based on the sales on product level in the first quarter 2012 and the Company's goal of achieving profitable growth, the Company anticipates that EBITDA growth on product level in the first quarter 2012 will be stronger than the sales increase on product level. In addition, based on the sales on product level for the first quarter 2012, the management board of aap is reiterating its full year 2012 outlook for a 10% sales increase on product level.

The Company's Q1 2012 report is scheduled for publication on May 15, 2012.

Diese Pressemitteilungen könnten Sie auch interessieren

Gerichtlicher Erfolg für Opalenburg - Anlegerin

, Finanzen & Versicherungen, CLLB Rechtsanwälte Cocron, Liebl, Leitz, Braun, Kainz Partnerschaft mbB

Mit Urteil vom 03.05.2018 (nicht rechtskräftig), hat das Landgericht München I entschieden, dass die Beteiligung einer von CLLB Rechtsanwälte...

Garantieniveau selbst festlegen: uniVersa bietet Airbag für Fondspolice an

, Finanzen & Versicherungen, uniVersa Versicherungen

In der anhaltenden Niedrigzinsphase werden fondsgebundene Rentenversicherungen verstärkt nachgefragt. Für Anleger, die bei der Altersvorsorge...

Top-Fonds Mai 2018: BlackRock Global Funds - World Technology Fund A2 EUR (LU0171310443 )

, Finanzen & Versicherungen, AVL Finanzvermittlung e.K.

Eigenständig recherchieren, das beste Finanzprodukt finden und dann zu günstigen Konditionen kaufen - so machen es die Kunden des Finanzvermittlers...

Disclaimer